GlassScriptPhysician profile
Ronit Z Sugar
NPI 1932193190
$1,076.85
in general payments reported to CMS, 2019-2025
18 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $107 · 2021: $11.03 · 2022: $39.44 · 2023: $163 · 2024: $213 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404 · Education: $72.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.68 |
| Education | $72.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $131.97 | 2023-2025 | Trodelvy |
| Celgene Corporation | $122.03 | 2019-2020 | |
| Hologic Sales and Service, LLC | $105.75 | 2024 | 3dimensions, Localizer, 3dquorum |
| Novartis Pharmaceuticals Corporation | $102.18 | 2019-2022 | |
| Eisai INC. | $100.59 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $84.14 | 2023-2025 | Lynparza, Keytruda |
| Puma Biotechnology, INC. | $77.50 | 2019-2020 | |
| Tesaro, INC. | $57.68 | 2019 | |
| Genentech USA, INC. | $54.54 | 2019 | |
| Daiichi Sankyo INC. | $47.04 | 2023 | Enhertu |
| Stemline Therapeutics INC. | $42.51 | 2024-2025 | Orserdu |
| Dilon Technologies, INC. | $41.00 | 2024 | Hemoblast Bellows |
| Bayer Healthcare Pharmaceuticals INC. | $27.46 | 2019 | |
| Ethicon US, LLC | $24.00 | 2024 | Enseal |
| Incyte Corporation | $18.18 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.73 | 2019 | |
| Merit Medical Systems INC | $11.52 | 2020 | |
| Myriad Genetic Laboratories, INC. | $11.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronit Sugar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.